Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Opinion in Neurology
|
July 16, 2021
Genetic therapy for congenital myopathies
Nika Maani, Sophie Karolczak, James J Dowling
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 15, 2018
Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease
Mo Zhao, Nika Maani, James J Dowling
Molecular Therapy. Nucleic Acids
|
April 11, 2025
microRNA-133a as an indicator of disease progression and treatment response in X-linked myotubular myopathy
Nika Maani, Dakota Gustafson, Peter MacDonald, et al.
Cancers
|
May 25, 2019
NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program
Nika Maani, Shelley Westergard, Joanna Yang, et al.
Disease Models & Mechanisms
|
June 13, 2022
Natural history of a mouse model of X-linked myotubular myopathy
Ege Sarikaya, Nesrin Sabha, Jonathan Volpatti, et al.
Nature Communications
|
November 20, 2018
Tamoxifen therapy in a murine model of myotubular myopathy
Nika Maani, Nesrin Sabha, Kamran Rezai, et al.
NPJ Genomic Medicine
|
July 20, 2021
Incidental findings from cancer next generation sequencing panels
Nika Maani, Karen Panabaker, Jeanna M McCuaig, et al.
Science Translational Medicine
|
February 18, 2026
AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy
Emanuela Pannia, Rebecca Simonian, Nesrin Sabha, et al.
Scientific Data
|
July 16, 2021
A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada
Isha Berry, Meghan O'Neill, Shelby L Sturrock, et al.
Acta Neuropathologica
|
July 17, 2022
X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition
Jonathan R Volpatti, Mehdi M Ghahramani-Seno, Mélanie Mansat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Opinion in Neurology
|
July 16, 2021
Genetic therapy for congenital myopathies
Nika Maani, Sophie Karolczak, James J Dowling
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 15, 2018
Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease
Mo Zhao, Nika Maani, James J Dowling
Molecular Therapy. Nucleic Acids
|
April 11, 2025
microRNA-133a as an indicator of disease progression and treatment response in X-linked myotubular myopathy
Nika Maani, Dakota Gustafson, Peter MacDonald, et al.
Cancers
|
May 25, 2019
NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program
Nika Maani, Shelley Westergard, Joanna Yang, et al.
Disease Models & Mechanisms
|
June 13, 2022
Natural history of a mouse model of X-linked myotubular myopathy
Ege Sarikaya, Nesrin Sabha, Jonathan Volpatti, et al.
Nature Communications
|
November 20, 2018
Tamoxifen therapy in a murine model of myotubular myopathy
Nika Maani, Nesrin Sabha, Kamran Rezai, et al.
NPJ Genomic Medicine
|
July 20, 2021
Incidental findings from cancer next generation sequencing panels
Nika Maani, Karen Panabaker, Jeanna M McCuaig, et al.
Science Translational Medicine
|
February 18, 2026
AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy
Emanuela Pannia, Rebecca Simonian, Nesrin Sabha, et al.
Scientific Data
|
July 16, 2021
A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada
Isha Berry, Meghan O'Neill, Shelby L Sturrock, et al.
Acta Neuropathologica
|
July 17, 2022
X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition
Jonathan R Volpatti, Mehdi M Ghahramani-Seno, Mélanie Mansat, et al.
Page
of 1